News

Discover 5 Stocks to Boost Your Portfolio This December

Discover 5 Stocks to Boost Your Portfolio This December

Understanding the Year-End Trading Phenomenon

As the year comes to a close, traders on Wall Street often find themselves debating a familiar question: will the Santa Claus rally be seen this year? Historically, the days between Christmas and the beginning of January tend to see a lift in stock prices, as investors engage in end-of-year trading activities fueled by optimism, tax-driven trades, and lighter market volumes.

This seasonal phenomenon has been a topic of discussion among market analysts for decades, and while some overlook it, the data reveals compelling patterns that consistently attract attention from investors.

S&P 500's Historical Performance During the Santa Rally

An analysis conducted on S&P 500 performance over the years shows that the Santa Claus rally tends to be a reality for many investors. Remarkably, data from the past 95 years indicates that between December 20 and January 4, there has been a 75.79% chance of the S&P 500 increasing, with an average gain of 1.7% during this timeframe.

In nearly a century of stock market history, there have been 72 instances of gains compared to just 23 declines, which further highlights the reliability of this pattern. Some notable years have marked significant gains, with 1991 being particularly outstanding, where the S&P 500 experienced an 8% rise during the holiday season.

While declines have occurred, notably a historical hammering of 8% between 1931 and 1932, most other dips during this period have been relatively contained, usually not exceeding a decline of 3.8%. This consistent performance prompts an important question: which stocks typically see an extra bounce during this season?

Top 5 Stocks to Track This December

Data over the past two decades sheds light on five specific stocks that frequently deliver impressive returns as the year wraps up. The analysis focuses on performance between December 16 and December 31.

  1. Illumina Inc. (NASDAQ: ILMN) has emerged as a standout during this festive season, posting gains in 17 of the past 20 years. This favorable track record equates to an impressive 85% success rate, with an average return of 4% during these critical weeks.
  2. Caterpillar Inc. (NYSE: CAT) follows closely, achieving a robust 80% winning rate with an average gain of 1.25%. Although its recent performance faltered, lost in 2024, Caterpillar had historically provided positive results for an impressive 14 consecutive years, demonstrating noteworthy reliability.
  3. JPMorgan Chase & Co. (NYSE: JPM) is another consistent performer, with stock prices rising in 15 of the last 20 years and an average return of 1.89%. Currently, the bank is enjoying a winning streak heading into December.
  4. Freeport-McMoRan (NYSE: FCX) brings an interesting element to this list, with its performance showcasing significant volatility. Holding a 70% success rate, Freeport-McMoRan has made headlines with several double-digit gains in late December, showing an average return of 3.54%. Recent gains include a surge of +11.2% in 2014, +13.95% in 2017, and +11.28% in 2020.
  5. Goldman Sachs Group Inc. (NYSE: GS) rounds out the top five, demonstrating gains in 13 of the last 20 years, leading to a 65% winning percentage and an impressive average return of 2.69%. This aligns well with the established patterns seen historically during the Santa rally.

Final Thoughts on Seasonal Stock Performance

While the historical patterns indicate that certain stocks see boosts during this festive season, it’s crucial to remember that the market is unpredictable. Investors may sometimes find themselves receiving ‘coal’ instead of the anticipated uphill move; hence caution is advised. The long-term trends suggest, however, that Santa tends to make his rounds—much to the delight of market participants.

Frequently Asked Questions

What is the Santa Claus rally?

The Santa Claus rally refers to the tendency for stock prices to rise in the last week of December and the first two trading days in January, influenced by various factors like tax-related trades and market optimism.

How often does the S&P 500 rise during the Santa rally?

Historically, the S&P 500 has risen 75.79% of the time during the Santa Claus rally period, with an average gain of approximately 1.7%.

Which stocks have historically performed well during this period?

Stocks like Illumina Inc. (ILMN), Caterpillar Inc. (CAT), JPMorgan Chase & Co. (JPM), Freeport-McMoRan (FCX), and Goldman Sachs Group Inc. (GS) have shown consistent performance and positive returns during the Santa rally periods.

Is the Santa rally guaranteed?

No, while historical data suggests a pattern, the market is unpredictable, and past performance does not guarantee future results.

What should investors consider during the Santa rally?

Investors should remain informed, manage their expectations, and be prepared for potential market fluctuations, while considering historical performance as one of several factors in decision-making.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 2

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 0

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Securiti Earns Noteworthy AWS Security Competency in AI

Updated Category News Views 375

Securiti Achieves AWS Security Competency Status in AI Security Securiti, the pioneer of the Data+AI Command Center, proudly announces its recent achievement of Amazon Web Services (AWS) Security Competency status in the innovative AI Security category. This new milestone highlights Securiti as one of the select inaugural partners recognized by AWS for its exceptional...

Continue Reading
Exciting Family Medicine Forum in Winnipeg This Fall

Updated Category News Views 204

Join the Family Medicine Forum in Winnipeg Mark your calendars, as the Family Medicine Forum is heading to Winnipeg this November for an enriching experience that promises to bring together family physicians from across the nation. This premier event is not only a chance to learn but to celebrate the vital work family doctors do every day. The Essence of Family Medicine...

Continue Reading
Man Group PLC Reveals Interest in Dowlais Group Securities

Updated Category News Views 106

Understanding the Disclosure by Man Group PLC In the realm of financial markets, disclosures play a crucial role in maintaining transparency and informing stakeholders about significant market movements. Recently, Man Group PLC made headlines by revealing its position regarding Dowlais Group PLC's relevant securities. This disclosure is essential as it reflects the...

Continue Reading
Experity Welcomes Bobby Ghoshal as New COO and President

Updated Category News Views 371

Experity Welcomes Bobby Ghoshal as President and COO Experity, a leader in on-demand healthcare solutions, has appointed Bobby Ghoshal as its new President and Chief Operating Officer. In this important role, Mr. Ghoshal will spearhead daily operations, steering the strategic direction for the company. His appointment is pivotal in enhancing Experity's mission to serve...

Continue Reading
LifeMD's Upcoming Engagements at Major Investor Conferences

Updated Category News Views 96

LifeMD's Upcoming Engagements at Major Investor Conferences LifeMD, Inc. (Nasdaq: LFMD), a trailblazer in virtual primary care, has recently announced its participation in several prominent investor conferences this September. As a company recognized for its innovative approach in telemedicine, LifeMD’s management is eager to showcase their vision and accomplishments to...

Continue Reading